167 related articles for article (PubMed ID: 15616316)
1. Molecular characterization of cefoxitin-resistant Escherichia coli from Canadian hospitals.
Mulvey MR; Bryce E; Boyd DA; Ofner-Agostini M; Land AM; Simor AE; Paton S
Antimicrob Agents Chemother; 2005 Jan; 49(1):358-65. PubMed ID: 15616316
[TBL] [Abstract][Full Text] [Related]
2. Similar cefoxitin-resistance plasmids circulating in Escherichia coli from human and animal sources.
Mulvey MR; Susky E; McCracken M; Morck DW; Read RR
Vet Microbiol; 2009 Mar; 134(3-4):279-87. PubMed ID: 18824313
[TBL] [Abstract][Full Text] [Related]
3. ampC gene expression in promoter mutants of cefoxitin-resistant Escherichia coli clinical isolates.
Tracz DM; Boyd DA; Hizon R; Bryce E; McGeer A; Ofner-Agostini M; Simor AE; Paton S; Mulvey MR;
FEMS Microbiol Lett; 2007 May; 270(2):265-71. PubMed ID: 17326753
[TBL] [Abstract][Full Text] [Related]
4. Mechanisms of resistance to expanded-spectrum cephalosporins in Escherichia coli isolates recovered in a Spanish hospital.
Briñas L; Lantero M; de Diego I; Alvarez M; Zarazaga M; Torres C
J Antimicrob Chemother; 2005 Dec; 56(6):1107-10. PubMed ID: 16239288
[TBL] [Abstract][Full Text] [Related]
5. The AmpC phenotype in Norwegian clinical isolates of Escherichia coli is associated with an acquired ISEcp1-like ampC element or hyperproduction of the endogenous AmpC.
Haldorsen B; Aasnaes B; Dahl KH; Hanssen AM; Simonsen GS; Walsh TR; Sundsfjord A; Lundblad EW
J Antimicrob Chemother; 2008 Oct; 62(4):694-702. PubMed ID: 18583329
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and molecular characterization of clinical isolates of Escherichia coli expressing an AmpC phenotype.
Jørgensen RL; Nielsen JB; Friis-Møller A; Fjeldsøe-Nielsen H; Schønning K
J Antimicrob Chemother; 2010 Mar; 65(3):460-4. PubMed ID: 20097787
[TBL] [Abstract][Full Text] [Related]
7. Molecular characterization of AmpC-producing Escherichia coli clinical isolates recovered at two Belgian hospitals.
Bogaerts P; Rodriguez-Villalobos H; Bauraing C; Deplano A; Laurent C; Berhin C; Struelens MJ; Glupczynski Y
Pathol Biol (Paris); 2010 Feb; 58(1):78-83. PubMed ID: 19892478
[TBL] [Abstract][Full Text] [Related]
8. Increase in ampC promoter strength due to mutations and deletion of the attenuator in a clinical isolate of cefoxitin-resistant Escherichia coli as determined by RT-PCR.
Tracz DM; Boyd DA; Bryden L; Hizon R; Giercke S; Van Caeseele P; Mulvey MR
J Antimicrob Chemother; 2005 May; 55(5):768-72. PubMed ID: 15761065
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the ampC promoter of Escherichia coli isolates resistant to oxyiminocephalosporins without extended spectrum beta-lactamase production.
Caroff N; Espaze E; Bérard I; Richet H; Reynaud A
FEMS Microbiol Lett; 1999 Apr; 173(2):459-65. PubMed ID: 10227175
[TBL] [Abstract][Full Text] [Related]
10. Prevalent phenotypes and antibiotic resistance in Escherichia coli and Klebsiella pneumoniae at an Indian tertiary care hospital: plasmid-mediated cefoxitin resistance.
Shahid M; Malik A; Akram M; Agrawal LM; Khan AU; Agrawal M
Int J Infect Dis; 2008 May; 12(3):256-64. PubMed ID: 17981482
[TBL] [Abstract][Full Text] [Related]
11. Sporadic occurrence of CMY-2-producing multidrug-resistant Escherichia coli of ST-complexes 38 and 448, and ST131 in Norway.
Naseer U; Haldorsen B; Simonsen GS; Sundsfjord A
Clin Microbiol Infect; 2010 Feb; 16(2):171-8. PubMed ID: 19548922
[TBL] [Abstract][Full Text] [Related]
12. Population-based laboratory surveillance for AmpC beta-lactamase-producing Escherichia coli, Calgary.
Pitout JD; Gregson DB; Church DL; Laupland KB
Emerg Infect Dis; 2007 Mar; 13(3):443-8. PubMed ID: 17552098
[TBL] [Abstract][Full Text] [Related]
13. [Investigation of plasmid-mediated AmpC beta-lactamase types in Klebsiella spp. and Escherichia coli isolates resistant or intermediate to cefoxitin].
Demirbakan H; Midilli K; Oğünç D; Ozen N; Ongüt G; Dağlar D; Mutlu D; Ozhak B; Colak D
Mikrobiyol Bul; 2008 Oct; 42(4):545-51. PubMed ID: 19149075
[TBL] [Abstract][Full Text] [Related]
14. Frequency of Plasmid-Mediated AmpC β-Lactamases in Escherichia coli Isolates from Urine Samples in São Paulo, Brazil.
Rocha DA; Campos JC; Passadore LF; Sampaio SC; Nicodemo AC; Sampaio JL
Microb Drug Resist; 2016 Jun; 22(4):321-7. PubMed ID: 26670152
[TBL] [Abstract][Full Text] [Related]
15. Emergence of imipenem resistance in clinical Escherichia coli during therapy.
Oteo J; Delgado-Iribarren A; Vega D; Bautista V; Rodríguez MC; Velasco M; Saavedra JM; Pérez-Vázquez M; García-Cobos S; Martínez-Martínez L; Campos J
Int J Antimicrob Agents; 2008 Dec; 32(6):534-7. PubMed ID: 18775649
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of phenotypic screening methods for detecting plasmid-mediated AmpC beta-lactamases-producing isolates of Escherichia coli and Klebsiella pneumoniae.
Lee K; Hong SG; Park YJ; Lee HS; Song W; Jeong J; Yong D; Chong Y
Diagn Microbiol Infect Dis; 2005 Dec; 53(4):319-23. PubMed ID: 16269222
[TBL] [Abstract][Full Text] [Related]
17. [CMY-2-type plasmid-mediated AmpC ß-lactamases emerging in Tucumán, Argentina].
Jure MA; Presti C; Cudmani NM; Grellet LM; López C; Musa EH; Aulet OC; Nieto C; Saavedra L; de Castillo MC
Rev Argent Microbiol; 2011; 43(1):24-7. PubMed ID: 21491062
[TBL] [Abstract][Full Text] [Related]
18. Characterization of Canadian cefoxitin-resistant non-typhoidal Salmonella isolates, 2005-06.
Mataseje LF; Xiao J; Kost S; Ng LK; Doré K; Mulvey MR;
J Antimicrob Chemother; 2009 Oct; 64(4):723-30. PubMed ID: 19638354
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of broad-spectrum cephalosporin-resistant Escherichia coli isolates in food samples in Tunisia, and characterization of integrons and antimicrobial resistance mechanisms implicated.
Ben Slama K; Jouini A; Ben Sallem R; Somalo S; Sáenz Y; Estepa V; Boudabous A; Torres C
Int J Food Microbiol; 2010 Feb; 137(2-3):281-6. PubMed ID: 20031243
[TBL] [Abstract][Full Text] [Related]
20. Appearance of Salmonella enterica isolates producing plasmid-mediated AmpC beta-lactamase, CMY-2, in South Korea.
Song W; Kim JS; Kim HS; Park MJ; Lee KM
Diagn Microbiol Infect Dis; 2005 Aug; 52(4):281-4. PubMed ID: 16165000
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
